CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
93 hedge funds and large institutions have $264M invested in Concert Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% less capital invested
Capital invested by funds: $264M → $264M (-$871K)
67% less call options, than puts
Call options by funds: $37K | Put options by funds: $113K
Holders
93
Holding in Top 10
3
Calls
$37K
Puts
$113K
Top Buyers
| 1 | +$9.17M | |
| 2 | +$5.99M | |
| 3 | +$3.58M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.41M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$2.36M |
Top Sellers
| 1 | -$6.33M | |
| 2 | -$5.27M | |
| 3 | -$4.04M | |
| 4 |
Morgan Stanley
New York
|
-$3.64M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.05M |